Relevant bibliographies by topics / Complementary medicines

Academic literature on the topic 'Complementary medicines'

Author: Grafiati
Published: 4 June 2021
Last updated: 31 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Complementary medicines.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Complementary medicines"

1

Ghaedi, Fateme, Mahlagha Dehghan, Masoumeh Salari, and Akbar Sheikhrabori. "Complementary and Alternative Medicines." Journal of Evidence-Based Complementary & Alternative Medicine 22, no. 2 (July 7, 2016): 210–15. http://dx.doi.org/10.1177/2156587215621462.

Full text
Abstract:
Prevalence of complementary and alternative medicines is increasing specially in patients with chronic diseases. Therefore, based on the high prevalence of chronic disorders, the present study aimed to determine complementary and alternative medicine usage frequency and its determinant factors. This was a cross-sectional study. Five hundred clients participated in the study by using convenience sampling. A 2-part questionnaire (including demographic form and researcher-created questionnaire) was used for studying the prevalence of using complementary and alternative medicine methods, and users’ satisfaction. Findings showed that 75.4% of people used at least one complementary and alternative medicine method. Most of users consumed medicinal plants (69.4%). The most common reason of using a complementary and alternative medicine method was common cold (32.9%). The highest satisfaction belonged to massage (2.94 ± 0.74). The usage of complementary and alternative medicine was 3.22 times higher in people with academic educations when compared with illiterate people. Concerning the high usage of complementary and alternative medicine, it is necessary to train specialists in this field in order to offer such treatments in a safe manner. Also, outcomes of application of complementary and alternative medicine methods should be studied.
APA, Harvard, Vancouver, ISO, and other styles
2

Burrow, Bruce. "Complementary medicines." Australian Prescriber 36, no. 2 (April 1, 2013): 40–41. http://dx.doi.org/10.18773/austprescr.2013.018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kayne, Steven. "Complementary medicines." Primary Health Care 6, no. 7 (July 1988): 16–17. http://dx.doi.org/10.7748/phc.6.7.16.s16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Prankerd, Richard J. "Complementary Medicines." Australian Journal of Hospital Pharmacy 30, no. 3 (June 2000): 93. http://dx.doi.org/10.1002/jppr200030393.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Alper, K. R., and S. D. Glick. "Psychotropic complementary medicines." British Journal of Psychiatry 188, no. 6 (June 2006): 587. http://dx.doi.org/10.1192/bjp.188.6.587-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

PhD, David C. K. Roberts. "Evaluating Complementary Medicines." Nutrition Bulletin 23, no. 1 (March 1998): 108–9. http://dx.doi.org/10.1111/j.1467-3010.1998.tb01090.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Carvalho, Ana Cecília Bezerra, João Paulo Silvério Perfeito, Leandro Viana Costa e Silva, Lívia Santos Ramalho, Robelma France de Oliveira Marques, and Dâmaris Silveira. "Regulation of herbal medicines in Brazil: advances and perspectives." Brazilian Journal of Pharmaceutical Sciences 47, no. 3 (September 2011): 467–73. http://dx.doi.org/10.1590/s1984-82502011000300004.

Full text
Abstract:
The National Policy of Integrative and Complementary Practices (PNPIC) in the Brazilian Unified Health System (SUS), and The National Policy of Medicinal Plants and Herbal Medicines (PNPMF) were launched in 2006. Based on these, the Brazilian Health Surveillance Agency (ANVISA) re-edited rules related to herbal medicines such as the Guideline to herbal medicine registration (RDC 14/10), the Good Manufacture Practices Guideline (RDC 17/10) and the List of references to assess the safety and efficacy of herbal medicines (IN 05/10). The requisites to prove herbal medicine's safety and efficacy were updated. Therefore, this review aims at presenting and commenting these new rules.
APA, Harvard, Vancouver, ISO, and other styles
8

Chituku, Sibongile, Cheryl Nikodem, and Alfred Maroyi. "Use of herbal, complementary and alternative medicines among pregnant women in Makoni District, Zimbabwe." Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas 21, no. 5 (September 30, 2022): 631–45. http://dx.doi.org/10.37360/blacpma.22.21.5.39.

Full text
Abstract:
Use of herbal, complementary and alternative medicines during pregnancy, labour and delivery is common in Zimbabwe. This study aimed at documenting herbal, complementary and alternative medicines used during pregnancy in Makoni District in Zimbabwe. Snowballing was used to select 66 participants which included herbalists (45.5%), traditional birth attendants (18.2%), traditional healers (15.2%), and assistant traditional healers and herbal medicine vendors (10.6% each). Pregnant women in the study areaused a total of 47 plant species from 27 families, and 14 non-plant products as herbal, complementary and alternative medicines by. A total of 26 medical cases were treated with the majority of medicinal plants and non-plant products,used to dilate or widen the birth canal (55.3%) and to augment labour or speed up the delivery process (46.8%). This study showed that herbal, complementary and alternative medicines play an important role in the provision of basic health care in Zimbabwe.
APA, Harvard, Vancouver, ISO, and other styles
9

Armour, Mike, Carolyn Ee, and Caroline Smith. "Complementary Therapies and Medicines and Reproductive Medicine." Seminars in Reproductive Medicine 34, no. 02 (February 11, 2016): 067–73. http://dx.doi.org/10.1055/s-0035-1571194.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Alsharif, Fatmah. "Discovering the Use of Complementary and Alternative Medicine in Oncology Patients: A Systematic Literature Review." Evidence-Based Complementary and Alternative Medicine 2021 (January 13, 2021): 1–9. http://dx.doi.org/10.1155/2021/6619243.

Full text
Abstract:
Background. Patients with cancer pursue all possible opportunities of effective remedies. In Saudi Arabia, most patients have tried complementary medicine during their cancer treatment plan; however, some complementary medicines might pose a danger to health. In Arab countries, studies regarding the use of complementary medicines and the intentions behind using complementary medicines among cancer patients are inadequate and all but nonexistent. The aim of this review was to focus on demographic, prevalence, and reasons for complementary and alternative medicine use among patients with cancer. Methods. A rigorous literature search was conducted for articles published in the English language, using the search terms “complementary and alternative medicine,” “oncology,” “malignancy” AND “cancer patients” in five scientific databases, namely, Medical Literature On-Line (MEDLINE), PubMed, Web of Science, Psychology Information (PsycINFO), and Google Scholar, from 2010 to 2020. Results. Of the 13,160 studies returned from the search, only 12 were eligible and included in this review. The combined prevalence for using complementary and alternative medicines across all studies totaled 25%–80% of cancer patients for the treatment of their cancers. Natural products, including vitamins and minerals, herbal products, and relaxation, were the most common type of complementary and alternative medicines used. The reason for using complementary and alternative medicines was reported to be their helpfulness in recovering, healing, and improving health. Most of the studies mentioned that participants obtained their complementary and alternative medicines from multiple sources, including the media, family and friends, and physicians. Conclusion. The use of complementary and alternative medicines in cancer patients can be inferred as an attempt to investigate all possibilities, a manifestation of a coping style, or an illustration of unmet desires in the cancer management continuum. Anyhow, there should be adequate communication between healthcare providers and patients, which is crucial for establishing a trusting healthcare provider-patient relationship. Relevance to clinical practice. It is crucial that healthcare providers explore the use of complementary and alternative medicines with their cancer patients, as well as educating them about the possible usefulness of therapies based on the available evidence.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Complementary medicines"

1

Braun, Lesley Anne, and lgbraun@bigpond net au. "Complementary Medicines in Hospitals - a Focus on Surgical Patients and Safety." RMIT University. Health Sciences, 2007. http://adt.lib.rmit.edu.au/adt/public/adt-VIT20080414.115624.

Full text
Abstract:
This study aimed to determine how CMs used by surgical patients are managed in the hospital system by doctors and pharmacists and what patient and practitioner influences affect this management. Research design and method Five systematic reviews were conducted to investigate the peer-reviewed literature for information about Australians use of CM; overseas and Australian doctors and CM; surgical patients use of CM and safety information about CMs in surgery as a basis to design and conduct three surveys. Surveys of hospital doctors, pharmacists and surgical patients were used to obtain measurement of people's attitudes, perceptions, behaviours and usage of CMs. For healthcare practitioners, knowledge of complementary medicines (CMs), past training, current practice and interest in future practice of complementary therapies (CTs) and education was also investigated. Approximately 50% of surgical patients reported taking CMs in the 2 weeks prior to surgery and approximately 50% of these patients intended to continue use in hospital. The most commonly used CMs were: fish oil supplements, multivitamins, vitamin C and glucosamine supplements as well as some CMs considered to potentially increase bleeding risk or induce drug interactions. It was not uncommon for CMs to be used at the same time as prescription medicines. Most surgical patients in general self-prescribe their CMs or have them recommended by family and friends whereas medical practitioners were the main prescribers to cardiac surgery patients. Nearly 60% of patients using CMs in the 2 weeks prior to admission did not tell hospital staff about use. The main reason for non-disclosure was not being asked about use whereas fear of a negative response was rarely a concern. The most common sources of information surgery patients refer to were GPs, pharmacists and health food stores. Hospital doctors and pharmacists did not routinely refer to information sources about CMs safety. The majority of doctors and pharmacists did not routinely ask patients about CMs, or record usage information. They had little training and knowledge of the evidence of commonly used CMs and lacked confidence in dealing with CMs-related issues. Their attitude to CMs is moderately negative and many are wary of safety, efficacy and cost-effectiveness issues. The majority of practitioners considered some CTs as potentially useful, particularly acupuncture, massage and meditation whereas the medicinal CTs and chiropractic were considered potentially harmful. Most practitioners were interested in future education about CMs and CTs and some would consider practising CTs. Personal usage of CTs was low although there was substantial interest in receiving future treatment. Despite many strategically orientated initiatives developed in Australia to promote evidence based medicine (EBM) and quality use of medicines (QUM), it appears that CMs have been largely ignored and overlooked in the practice of Medicine and Pharmacy within the hospital system. Furthermore, it appears that in regards to CMs a 'don't ask, don't tell, don't know' culture exists within hospitals and that evidence based patient-centred care and concordance is not being achieved and potentially patient safety and wellbeing is being compromised.
APA, Harvard, Vancouver, ISO, and other styles
2

Patnala, Satya Siva Rama Ranganath Srinivas. "Pharmaceutical analysis and quality of complementary medicines : sceletium and associated products." Thesis, Rhodes University, 2007. http://hdl.handle.net/10962/d1018263.

Full text
Abstract:
There has been an upsurge in the use of Complementary and Alternate Medicines (CAMs) in both developed and developing countries. Although herbal medicines have been in use for many centuries, their quality, safety and efficacy are still of major concern. Many countries are in the process of integrating CAMs into conventional health care systems based on the knowledge and use of traditional medicines. The quality control (QC) of herbal products usually presents a formidable analytical challenge in view of the complexity of the constituents in plant material and the commercial non-availability of appropriate qualified reference standards. Sceletium, a genus belonging to the family Aizoaceae, has been reported to contain psychoactive alkaloids, specifically mesembrine, mesembrenone, mesembrenol and some other related alkaloids. Sceletium is marketed as dried plant powder and as phyto-pharmaceutical dosage forms. Sceletium products and plant material marketed through health shops and on the internet are associated with unjustified claims of specific therapeutic efficacy and may be of dubious quality. Validated analytical methods to estimate Sceletium alkaloids have not previously been reported in the scientific literature and the available methods have focused only on qualitative estimation. Furthermore, since appropriate markers were not commercially available for use as reference standards, a primary objective of this study was to isolate relevant compounds, qualify them as reference standards which could be applied to develop appropriate validated qualitative and quantitative analytical methods for fingerprinting and assay of Sceletium plant material and dosage forms. The alkaloidal markers mesembrine, mesembrenone and ∆⁷ mesembrenone were isolated by solvent extraction and chromatography from dried plant material. Mesembranol and epimesembranol were synthesised by hydrogenation of the isolated mesembrine using the catalyst platinum (IV) oxide and then further purified by semi-preparative column chromatography. All compounds were subjected to analysis by ¹H, ¹³C, 2-D nuclear magnetic resonance and liquid chromatography-tandem mass spectroscopy. Mesembrine was converted to hydrochloride crystals and mesembranol was isolated as crystals from the hydrogenation reaction mass. These compounds were analysed and characterised by X-ray crystallography. A relatively simple HPLC method for the separation and quantitative analysis of five relevant alkaloidal components in Sceletium was developed and validated. The method was applied to determine the alkaloids in plant material and dosage forms containing Sceletium. An LCMS method developed during the study provided accurate identification of the five relevant Sceletium alkaloids. The method was applied for the quantitative analysis and QC of Sceletium plant material and its dosage forms. This LCMS method was found to efficiently ionize the relevant alkaloidal markers in order to facilitate their detection, identification and quantification in Sceletium plant material as well as for the assay and QC of dosage forms containing Sceletium. The chemotaxonomy of some Sceletium species and commercially available Sceletium dosage forms were successfully studied by the LCMS method. The HPLC and LCMS methods were also used to monitor the bio-conversion of some of the alkaloids while processing the plant material as per traditional method of fermentation. Additionally a high resolution CZE method was developed for the separation of several Sceletium alkaloids in relatively short analysis times. This analytical method was used successfully to fingerprint the alkaloids and quantify mesembrine in Sceletium and its products. Sceletium species grown under varying conditions at different locations, when analyzed, showed major differences in their composition of alkaloids and an enormous difference was found to exist between the various species with respect to the presence and content of alkaloids. Sceletium and its products marketed through health shops and the internet may thus have problems with respect to the quality and related therapeutic efficacy. The QC of Sceletium presents a formidable challenge as Sceletium plants and products contain a complex mixture of compounds. The work presented herein contributes to a growing body of scientific knowledge to improve the QC standards of herbal medicines and also to provide vital information regarding the selection of plant species and information on the specific alkaloidal constituents to the cultivators of Sceletium and the manufacturers of its products.
APA, Harvard, Vancouver, ISO, and other styles
3

Mupfumira, Rudo. "An assessment of African traditional medicines in pregnancy and on birth outcomes: pharmacists' perceptions of complementary medicines in pregnancy." Thesis, Rhodes University, 2012. http://hdl.handle.net/10962/d1003256.

Full text
Abstract:
Increasing numbers of medicines are being used by pregnant South African women in the public sector during pregnancy, for the treatment of different biomedical and supernatural disease states and conditions. The motivation for the research is to support the development of more local pregnancy registries in order to strengthen evidence for the safety and efficacy of medicines used in pregnancy. A mixed methods approach was used. Women in their ninth month of pregnancy in a public sector setting, and four community pharmacists were identified. The women who met the inclusion criteria were recruited. One in-depth semi-structured interview was conducted with each woman before giving birth and data on their pregnancy outcomes were collected after labour. Coincidentally, the mother of one of the participants was found to be a traditional healer. She was also interviewed on the topic. A structured questionnaire was administered to the pharmacists. Ten pregnant women between the ages of 19 to 39 who had used or were using a traditional medicine during the pregnancy were recruited. All the participants had had at least one antenatal check up during their pregnancy with one having attended five times. No abnormal results were reported from any of the check ups or tests done during the visits. All of them had been to school and had at least Standard 8/Grade 10 education. Ten babies were seen between one and four days postpartum and no birth defects were obvious or were reported for any of them. The traditional healer did not provide additional information to what the women had said and confirmed that some of the practices the women reported were known to her as traditional medicine practices. All four pharmacists indicated that they considered complementary and alternative medicines (CAMs) to be “somewhat effective” and sold them at their pharmacies although none of them were aware of whether or not they were registered with the MCC. None of the pharmacists appeared to have an in-depth knowledge of traditional, complementary and alternative medicines (TCAMs). All four pharmacists said that it is important to have a basic understanding of TCAMs before using them, although they did not agree on the reasons for this. All of them felt that pharmacists have a professional responsibility to provide information on TCAMs (especially herbal preparations) and two felt that providing this information is part of a medical doctors’ responsibility. No harm from taking TCAMs could be shown. However herbal medicines have numerous ingredients some of which are unknown and taking these medicines is risky. The pharmacists in this sample were unsure whether they were accessing unreliable CAM information. Reliable sources of information and reference materials on CAMs to assist pharmacists and other healthcare professionals are needed. The apparent widespread use of TCAM in pregnancy indicates a need for documentation about its efficacy and safety. The establishing of TCAM pregnancy registries should seriously be considered. Due to the increase in CAM use, CAM education during pharmacists’ training as well as continuing professional development (CPD) in CAM for pharmacists in practice should be encouraged.
APA, Harvard, Vancouver, ISO, and other styles
4

Awortwe, Charles. "Pharmacokinetic herb-drug interaction study of selected traditional medicines used as complementary and alternative medicine (CAM) for HIV/AIDS." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96796.

Full text
Abstract:
Thesis (DMed)--Stellenbosch University, 2015
ENGLISH ABSTRACT: Introduction The increasing intake of traditional medicines among HIV/AIDS patients in sub-Saharan Africa needs urgent consideration by clinicians and other healthcare providers since the safety of such medications are unknown. The pharmacokinetic parameters - Absorption, Distribution, Metabolism and Elimination (ADME) play important role in the safety evaluation of drugs, thus implicating drug metabolizing enzymes and transporters as critical indicators for herb-drug interactions. The objective of this study was to evaluate the risk potential of seven herbal medicines commonly consumed by HIV/AIDS patients for drug interactions applying in vitro models. In this study, inhibition and induction effects of the herbal medicines on cytochrome P450s (CYPs) 1A2, 2C9, 2C19, 2D6 and 3A4 as well as P-glycoprotein (P-gp) were investigated. Methods Herbal medicines – Lessertia frutescens, Hypoxis hemerocallidea, Kalanchoe integra and Taraxacum officinale were sourced from Medico Herbs, South Africa were identified by experts from Compton Herbarium, South African National Biodiversity Institute, Cape Town. Moringa oleifera, Echinacea purpurea and Kalanchoe crenata were obtained from the repository of the National Centre for Natural Product Research (NCNPR), University of Mississippi, USA. Reversible inhibitory effect of aqueous and methanol herbal extracts were evaluated in recombinant CYPs applying the fluorescent metabolites at specified excitation/emission wavelengths; CYP1A2 (3-cyano-7-hydroxycoumarin (CHC); 405/460 nm), CYP2C9, CYP2C19 and CYP3A4 (7-hydroxy-4-(trifluoromethyl)-coumarin (HFC); 405/535 nm) and CYP2D6 (7-hydroxy-4-(aminomethyl)-coumarin (HAMC); 390/460 nm). Comparative studies in human liver microsomes (HLM) and recombinant CYPs were conducted to investigate the inhibitory effect of methanol herbal extracts and fractions on 6β testosterone hydroxylation activity. Time dependent inhibitory (TDI) effect of the herbal extracts were evaluated applying the IC50 shift fold, normalized ratio and the NADPH-, time- and concentration-dependent approaches. Influence of herbal extracts on metabolic clearance of testosterone was assessed in both HLM and human hepatocytes. The effects of each herbal extract on expression of CYP1A2, CYP3A4 and MDR1 genes were evaluated in activated human pregnane X receptor (PXR) co-transfected HepG2 cells. Finally, the inhibitory effect of herbal extracts on P-gp was assessed using the calcein-acetoxymethyl ester (calcein-AM) uptake and the digoxin radiolabelled substrates in MDCKII-MDRI cells. Results The aqueous extracts of Moringa oleifera, Kalanchoe integra, Kalanchoe crenata, Echinacea purpurea and Lessertia frutescens demonstrated high risk of in vivo inhibition on CYPs 3A4 and 1A2 with Cmax/Ki >1.0. Methanol extracts of these herbal medicines also indicated potential risk of reversible drug interaction. The methanol extracts of M. oleifera, K. crenata and L. frutescens showed strong TDI effect on CYP3A4 with IC50 shift fold >1.5 and normalised ratio <0.7. Moringa oleifera intermediately reduced intrinsic clearance of testosterone in human hepatocytes (2 ≤ AUC ratio ≤ 5) when scaled up to humans. Methanol extracts of Echinacea purpurea up-regulated the expression of CYP1A2, CYP3A4 and MDR1 genes in activated PXR. Kalanchoe crenata and Echinacea purpurea indicated strong inhibition on P-gp by reducing transport of digoxin across hMDR1-MDCKII cell monolayer from basolateral to apical with IC50 values of 18.24 ± 2.52 μg/mL and 24.47 ± 4.97 μg/mL, respectively. Conclusion The herbal medicines especially M. oleifera, K. integra and E. purpurea have the potential to cause herb-drug interaction in vivo if sufficient hepatic concentration is achieved in humans.
AFRIKAANSE OPSOMMING: Inleiding Die verhoogde inname van tradisionele medisynes onder MIV/VIGS-pasiënte in sub-Sahara-Afrika verg dringend oorweging deur klinici en ander gesondheidsorgverskaffers, aangesien die veiligheid van sodanige medikasies onbekend is. Die farmakokinetiese parameters – Absorpsie, Distribusie, Metabolisme en Eliminasie (ADME) – speel ’n belangrike rol by die veiligheidsevaluering van geneesmiddels, en impliseer gevolglik geneesmiddel-metaboliserende ensieme en vervoerders as kritiese indikators vir krui-geneesmiddel-interaksies (HDI). Die oogmerk van hierdie studie is om die risikopotensiaal van sewe kruiemedisynes wat algemeen deur MIV/VIGS-pasiënte geneem word, vir geneesmiddel-interaksies te evalueer deur in vitro-modelle te gebruik. In hierdie studie is die inhiberings- en induseringsuitwerkings van die kruiemedisynes op sitochroom P450’s (verkort na CYP’s) 1A2, 2C9, 2C19, 2D6 en 3A4, sowel as P-glikoproteïen (P-gp), ondersoek. Metodes Kruiemedisynes – Lessertia frutescens, Hypoxis hemerocallidea, Kalanchoe integra en Taraxacum officinale – is van Medico Herbs, Suid-Afrika, bekom en deur kundiges van die Compton-herbarium, by die Suid-Afrikaanse Nasionale Biodiversiteitsinstituut, Kaapstad, geïdentifiseer. Moringa oleifera, Echinacea purpurea en Kalanchoe crenata is van die bewaarplek van die Nasionale Sentrum vir Natuurlike Produknavorsing (NCNPR) aan die Universiteit van Mississippi in die VSA verkry. Die omkeerbare inhiberende uitwerking van kruie-ekstrakte in water en metanol is in rekombinante CYP’s geëvalueer deur die gebruik van die fluoresserende metaboliete op gespesifiseerde opwekkings-/emissiegolflengtes; CYP1A2 (3-siaan-7-hidroksikumarien (CHC); 405/460 nm), CYP2C9, CYP2C19 en CYP3A4 (7-hidroksi-4-(trifluoormetiel)-kumarien (HFC); 405/535 nm) en CYP2D6 (7-hidroksi-4-(aminometiel)-kumarien (HAMC); 390/460 nm). Vergelykende studies van menslikelewermikrosome (HLM) en rekombinante CYP’s is uitgevoer om die inhiberende uitwerking van metanolkruie-ekstrakte en -fraksies op 6β-testosteroonhidroksileringsaktiwiteit te ondersoek. Die tydafhanklike inhiberende uitwerking (TDI) van die kruie-ekstrakte is geëvalueer deur gebruikmaking van die IC50-verskuiwingsvou-, die genormaliseerdeverhoudings- en die NADPH-, tyd- en konsentrasieafhanklike benaderings. Die invloed van kruie-ekstrakte op metaboliese testosteroonverheldering is in beide HLM en menslike hepatosiete geëvalueer. Die uitwerkings van elke kruie-ekstrak op die uitdrukking van CYP1A2-, CYP3A4- en MDR1-gene is in geaktiveerde menslike pregnaan-X-reseptor(PXR)-, ko-getransfekteerde HepG2-selle geëvalueer. Laastens is die inhiberende uitwerking van kruie-ekstrakte op P-gp geëvalueer, met gebruikmaking van die kalsien-asetoksimetiel-ester (kalsien-AM)-opname en die digoksien- radiogemerkte substrate in MDCKII-MDRI-selle. Resultate Die ekstrakte in water van M. oleifera, K. integra, K. crenata, E. purpurea en L. frutescens het ’n hoë risiko van in vivo-inhibering op CYP’s 3A4 en 1A2 met Cmaks/Ki >1.0 getoon. Ekstrakte van hierdie kruiemedisynes in metanol het verder potensiële risiko van omkeerbare geneesmiddelinteraksie getoon. Die ekstrakte van M. oleifera, K. crenata en L. frutescens in metanol het sterk TDI-uitwerking op CYP3A4 met IC50-verskuiwingsvou >1.5 en genormaliseerde verhouding <0.7 getoon. M. oleifera het intermediêre vermindering van intrinsieke testosteroonverheldering in menslike hepatosiete (2 ≤ AUC verhouding ≤ 5) tot gevolg wanneer die skaal na mense verhoog word. Ekstrakte van E. purpurea in metanol het die uitdrukking van CYP1A2-, CYP3A4- en MDR1-gene in geaktiveerde PXR opgereguleer. K. crenata en E. purpurea het sterk inhibering van P-gp getoon deur die vervoer van digoksien deur die hMDR1-MDCKII-selmonolaag van basolateraal tot apikaal met IC50-waardes van onderskeidelik 18.24 ± 2.52 μg/mL en 24.47 ± 4.97 μg/mL te verminder. Gevolgtrekking Kruiemedisynes, veral M. oleifera, K. integra en E. purpurea, het die potensiaal om HDI in vivo te veroorsaak indien voldoende hepatiese konsentrasie by mense bereik word.
APA, Harvard, Vancouver, ISO, and other styles
5

Lawrance, Jennifer Kristy. "Complementary and Alternative Medicines: The Knowledge, Attitudes and Practices of Dietitians in Maine." Fogler Library, University of Maine, 2002. http://www.library.umaine.edu/theses/pdf/LawranceJK2002.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Boehm, Katja. "Acquisition, distribution and perspectives of healthcare information in complementary and alternative medicines (CAM)." Thesis, University of Plymouth, 2006. http://hdl.handle.net/10026.1/2500.

Full text
Abstract:
There is an underlying need to gather information for a better understanding of the mechanisms of action, safety, efficacy and cost-effectiveness of CAM. Once this information has been collected, the research needs to be distributed amongst healthcare professionals, the public and governing bodies. In my work, I looked at the range of German and UK general practitioners' attitudes toward CAM and medical students' CAM attitudes in the UK, USA, Canada, New Zealand and Hong Kong. GPs' CAM attitudes did not differ across countries but a lack of information regarding safety and efficacy, as well as CAM training opportunities were criticized. CAM education was found to vary across countries due to different curricula and personal CAM use was a better predictor of CAM attitudes than was CAM exposure in the medical schools' curricula. I furthermore collected information on how CAM practitioners respond to specific patient and researcher health queries via e-mail. Medical herbalists, chiropractors, reflexologists, acupuncturists and homeopaths were contacted. lt was found that response rates to a fictitious patient were significantly higher than those given to a researcher. Some of the advice given online was interpreted as misleading or dangerous. Regulations for CAM practitioners dealing with potential clients' postal or online health queries should be put in place. I co-authored various systematic reviews, which summarize data from clinical trials and thus assessed the efficacy of mistletoe, co-enzyme Q10, guided imagery acupuncture and Ukrain for cancer care and music therapy for cardiovascular conditions. To summarize these reviews I conclude that some CAM modalities play an important role as an adjunct to conventional medicine in palliative cancer care and are based on a non-specific effect. Specific effects of CAM for certain health conditions are rather small. There is a need to regulate how CAM information is distributed. More rigorous clinical trials need to be financed and carried out independently to assess CAM efficacy and safety in those CAM modalities where a specific effect is suspected and in others with non-specific effects possibly CAM therapist evaluations should be carried out. Further international regulations should be put in place regarding CAM education in medical schools and CAM training for healthcare professionals.
APA, Harvard, Vancouver, ISO, and other styles
7

Song, Hyon W., Marion Slack, Jennie Lee, and Bismark Baidoo. "A Meta-Analysis of Alternative and Complementary Medicine for the Treatment of Insomnia." The University of Arizona, 2013. http://hdl.handle.net/10150/614292.

Full text
Abstract:
Class of 2013 Abstract
Specific Aims: To evaluate three complementary and alternative medicines (CAM), tai-chi, acupuncture, and melatonin, for treating insomnia using meta-analysis assessment of randomized controlled trials. Methods: The electronic database MEDLINE (PubMed) was searched from May of 2012 to November of 2012 by using the terms “sleep initiation and maintenance disorders” AND “tai-chi” OR “melatonin” OR “acupuncture”. All of the searches ended at November of 2012. Data extraction was conducted independently by 2 investigators and any disagreements were resolved by consensus. If the 2 investigators could not agree, the study was reviewed by all 4 investigators. Main Results: Out of 500 studies that were initially retrieved, 12 studies were included; 3 for tai-chi; 4 for acupuncture; 5 for melatonin. We found that the effect of each type of intervention was significantly different than zero, p<0.01 thus all were effective in treating insomnia. From our analysis, acupuncture was the most effective (standard mean difference, SMD=-0.66; p<0.01) followed by tai-chi (SMD=-0.43; p<0.01) whereas melatonin was the least effective (SMD=-0.26; p=0.04) but difference between acupuncture and melatonin was not significant (p=0.15).       Conclusion: All three interventions were found to be effective in treating insomnia. However, due to mixed and inconsistent data of the studies, poorly designed trials, and small sample size, further large, well-controlled trials are warranted.
APA, Harvard, Vancouver, ISO, and other styles
8

Catterson, Sandra Lynne. "Complementary and alternate medicines: a forensic analysis of the potential adulteration of over-the-counter anorectics and "lifestyle" medicines in South Africa." Master's thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/27059.

Full text
Abstract:
Background: Complementary and Alternate Medicines (CAMs) in South Africa are not yet subjected to the same rigorous testing required for allopathic (prescription) medication, yet they are freely available as over-the-counter medicines. Past research has shown the presence of a banned drug, sibutramine in natural anorectics and a schedule 6 prescription drug, sildenafil, found in natural erectile dysfunction preparations. Methods: Initially, 26 exhibits (18 erectile dysfunction medicines and 8 anorectics) were screened for active pharmaceutical ingredients using high performance liquid chromatography tandem mass spectrometry. An AB SCIEX 3200 TRAP® linear ion-trap quadrupole mass spectrometer was used to detect and subsequently quantitate these active pharmaceutical ingredients using a targeted multiple reaction monitoring mode. Samples were extracted with 50% v/v methanol in water. A method for the quantitation of sildenafil was subsequently partially validated. The intra- and inter-assay precisions were evaluated and the linearity of the method was investigated in the range of 20 ng/mL to 2000 ng/mL. The method was then successfully applied to a random selection of CAMs. A random sample (n=61) of erectile dysfunction CAMs were selected for quantitation from two different clusters. Cluster 1 comprised of supermarkets and cluster 2 of pharmacies. Results: The validation method for sildenafil showed that the limit of detection was 1.09 ng/mL and the limit of quantitation was 20 ng/mL. The correlation co-efficient and bias were less than 20%. Initial screening of the 26 exhibits indicated that sildenafil was present in 12 of the 18 samples tested and sibutramine in 6 of the 8 anorectics. Of the later 61 exhibits tested, 43 tested positive for sildenafil. The mass of sildenafil per sample ranged from 1.09 ng/mL to 123.7 mg/sample. Conclusion: The lack of label content, regulation and legislation exposes the consumer to the risk of consuming an active pharmaceutical ingredient which may very likely have an adverse effect on their health. There is a need to raise public awareness to the potential dangers of unregulated CAMs, encourage doctors to become more aware of their patients' consumption of CAMs and to motivate the Medicines Control Council to follow through with their deadlines for the regulation of CAMs.
APA, Harvard, Vancouver, ISO, and other styles
9

Clark-Grill, Monika Maria, and n/a. "Reclaiming the full story of human health : the ethical significance of complementary and alternative medicines." University of Otago. Dunedin School of Medicine, 2005. http://adt.otago.ac.nz./public/adt-NZDU20060808.142253.

Full text
Abstract:
This thesis investigates the moral content of illness ontologies in different healing systems, in particular biomedicine and homeopathy. It was motivated by the wish to gain a greater understanding of the possible meaning and ethical significance underlying the increasing popularity of complementary and alternative medicine (CAM) in Western countries. CAM is an umbrella term for a diverse group of therapeutic approaches, indicating their marginalized status in relation to conventional, scientific medicine. However, despite their diversity most CAM share a common bond by subscribing to a holistic perspective on life, health and illness. It is for this reason that this thesis concentrates on the conceptual level. The subject is approached by making use of interview material from five homeopathic doctors from Austria. Their perspective on different aspects of non-conventional, as well as biomedical, practice and underlying theory provides the springboard for theoretical investigations. The demand for scientific evidence of CAM is critically examined. The issue of increasing pluralism in health care is explored, along with its challenge of finding appropriate epistemological approaches for therapeutic systems that are based on different illness ontologies. The favored approach in this thesis is based on the recognition by medical historians that there are four basic illness axioms: "illness as loss of balance", "illness as disruption of interpersonal communication", "illness as a physical defect" and "illness as pathic creation". These axioms are matched respectively with four different epistemic pathways: the dialectical, the hermeneutical, the analytical and the phenomenological. The interviewees considered the more humane quality of the doctor/patient relationship in their homeopathic practices to be due to the holistic premises of homeopathy, which place the subjective dimension of patients at their center. The difficulty of achieving informed consent in the commonly used sense in homeopathic practice was solved by engaging in a shared decision-making process. Life was explained by the interviewees in vitalistic terms. Although rejected by science, the notion of vitalism appears to hold significance for the public. Illness was always perceived as a multidimensional process and not as a purely physico-chemical dysfunction. It became evident that the holistic perspective takes account of the many dimensions of human illness, of which neither the conventional reductionist conception nor the dualistic mind/body approach are capable. However, the unmanageable complexity of holism poses a problem for therapeutic practice. A conceptual approach providing some structure for the holistic multidimensionality is found in the four illness axioms and in analogous observations by Aristotle. It is concluded that there could be a connection between the increased popularity of CAM and their underlying holistic perspective, since this theoretical foundation allows the practitioner to address the patient in a whole-person way. At the same time the holistic perspective provides a much broader scope than biomedicine for patients to influence their health. The recognition that human multidimensionality needs to be appreciated at the level of illness ontology may also provide an impetus for bioethics to approach contemporary ethical challenges from a perspective of an ethics of the good life, instead of concerning itself predominantly with setting limits in the arena of technological medicine.
APA, Harvard, Vancouver, ISO, and other styles
10

TYMBIOS, Joanna Antonia. "An evaluation of western herbal complementary medicine labelling in South Africa, to determine whether the product labelling information complies with established herbal monographs and whether it meets local regulatory requirements." University of the Western Cape, 2015. http://hdl.handle.net/11394/5111.

Full text
Abstract:
Magister Pharmaceuticae - MPharm
Medicines (CMs) are widely available to the South African public. However, CMs have not yet been evaluated by the Medicines Control Council (MCC). The MCC has published new guidelines for the regulation of CMs, with which CM companies are required to comply. OBJECTIVE: Determine to what degree Western Herbal CM labelling complies with the MCC’s requirements. METHODS: Thirteen CM products containing recognised Western Herbal ingredients were selected from pharmacies in the northern suburbs of Johannesburg. Labelling information on the immediate and outer container labels, as well as the package inserts, was investigated. The relevant corresponding European Medicines Agency (EMA) monographs and MCC guidelines were used to assess compliance. RESULTS: None of the products complied with the product dosage section of the monographs. Furthermore, the products contained indications that were not present in the monographs. The products did not fully meet the MCC’s mandatory minimum labelling requirements, and they did not demonstrate total compliance with all of the MCC’s requirements for product labels and package inserts.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Complementary medicines"

1

Sointu, Eeva. Theorizing Complementary and Alternative Medicines. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137003737.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Perspectives on complementary and alternative medicines. London: Imperial College Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

R, Avila Juan, ed. Professional's handbook of complementary & alternative medicines. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

The other medicines. Garden City, N.Y: Doubleday, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Harikumar, K. B., ed. Complementary and Alternative Medicines in Prostate Cancer. Boca Raton, FL : CRC Press, Taylor & Francis Group, 2017. |: CRC Press, 2016. http://dx.doi.org/10.1201/9781315370156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

1965-, Cant Sarah, and Sharma Ursula 1941-, eds. Complementary and alternative medicines: Knowledge in practice. London: Free Association Books, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sointu, Eeva. Theorizing complementary and alternative medicines: Self, gender, class. Basingstoke, Hampshire: Palgrave Macmillan, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

The Legal status of complementary medicines in Europe. Berne: Stæmpfli Publishers, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Stimson, Nina, ed. Herbal, Alternative and Complementary Medicines. Connecting to New Realities. Southend-On-Sea, United Kingdom: Nicholas Hall & Co, Southend-On-Sea, United Kingdom, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

service), SpringerLink (Online, ed. Materia Medica of New and Old Homeopathic Medicines. Berlin, Heidelberg: Springer-Verlag GmbH Berlin Heidelberg, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Complementary medicines"

1

Fox, Anthony W. "Complementary Medicines." In Principles and Practice of Pharmaceutical Medicine, 399–405. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444325263.ch33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ware, Mark A. "Complementary and Alternative Medicines." In Clinical Pain Management, 215–23. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444329711.ch26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Toniol, Rodrigo. "Complementary and Alternative Medicines." In Encyclopedia of Latin American Religions, 1–3. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-08956-0_11-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Toniol, Rodrigo. "Complementary and Alternative Medicines." In Encyclopedia of Latin American Religions, 357–58. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-27078-4_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tan, Patricia. "Complementary and alternative medicines." In Brand Medicine, 274–95. London: Palgrave Macmillan UK, 2001. http://dx.doi.org/10.1057/9780230522510_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Britten, Nicky. "Self-care and Complementary Therapies." In Medicines and Society, 25–44. London: Macmillan Education UK, 2008. http://dx.doi.org/10.1007/978-1-137-14397-6_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wicks, Sheila M., and Gail B. Mahady. "Herbal and Complementary Medicines Used for Women’s Health." In Medicines For Women, 373–99. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12406-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sointu, Eeva. "Introduction." In Theorizing Complementary and Alternative Medicines, 1–20. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137003737_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sointu, Eeva. "Conclusions." In Theorizing Complementary and Alternative Medicines, 208–16. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137003737_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sointu, Eeva. "Landscapes of Complementary and Alternative Health." In Theorizing Complementary and Alternative Medicines, 21–42. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137003737_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Complementary medicines"

1

Ziak, M. "Regulation of herbal and complementary medicines in Switzerland." In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Corell Domenech, María Vicenta, and Olga Mayoral García-Berlanga. "WHAT DO TEACHER TRAINING STUDENTS THINK ABOUT COMPLEMENTARY AND ALTERNATIVE MEDICINES?" In 10th International Conference on Education and New Learning Technologies. IATED, 2018. http://dx.doi.org/10.21125/edulearn.2018.2323.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Spanakis, Marios, Stelios Sfakianakis, Emmanouil G. Spanakis, George Kallergis, and Vangelis Sakkalis. "PDCA: An eHealth service for the management of drug interactions with complementary and alternative medicines." In 2018 IEEE EMBS International Conference on Biomedical & Health Informatics (BHI). IEEE, 2018. http://dx.doi.org/10.1109/bhi.2018.8333446.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

"Role of Complementary and Alternative Medicine (CAM) in building the future of the Healthcare Sector in Pakistan." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/ucvo7515.

Full text
Abstract:
Background: More than 70% of the developing world's population still depends on complementary and alternative systems of medicine (CAM). Despite today's advancements, a large segment of the population still depends on traditional medicine or so-called alternative medicine as the preferred form of health care. So there is a need to consider the role of complementary and alternative medicine in public healthcare. Objective: To identify the population's exposure to the traditional medicine To explore the rich diversity of medicinal plants in Pakistan To identify the areas that can play a crucial role in the healthcare sector of Pakistan Method: A narrative review study has been conducted. Data has been collected from different articles from different search engines i.e. Google Scholar, PubMed and Science Direct. A total of 10 articles are being referenced in the main article while reading the literature involves the 150+ articles Results: Almost 70 species of the 430 wild species In the western part of the Himalayas had been examined. About 40% of flora species have been used for the treatment of diseases relating to Gastrointestinal (GIT). It was discovered that most of the species 12 to sixteen species) sought to deal with human and farm animals' digestive system-related issues, respectively. Conclusion: Pakistan has unique biodiversity, having nine major ecological zones. Due to its unique climate, the country is very rich in medicinal and endemic plants distributed in its large area. The highlands of northern Pakistan are the hot spots of biodiversity and are rich in medicinal and endemic species. These plants are still commonly used for medicinal purposes by people in their daily lives. This region, which is rich in medicinal plants, still needs more exploration and study. Keywords: Traditional medicine, CAM, Healthcare sector in Pakistan
APA, Harvard, Vancouver, ISO, and other styles
5

Medeiros, Kaline Araújo, Cláudio Chaves Cavalcante-Neto, Elisana Afonso de Moura Pires, Thaísa Leite Rolim Wanderley, and Milen Maria Magalhães de Souza Fernandes. "A FITOTERAPIA COMO AUXILIAR NOS CUIDADOS DOS TRANSTORNOS DE ANSIEDADE E INSÔNIA DO PACIENTE ACOMETIDO PELA COVID-19." In II Congresso Brasileiro de Ciências Farmacêuticas On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/1045.

Full text
Abstract:
Introdução: Historicamente as plantas medicinais foram utilizadas com diversas aplicações ressaltando-se o potencial alimentício, medicinal e tóxico. Na contemporaneidade com a pandemia da COVID-19 o aspecto medicinal de muitas espécies tem sido aplicado. Dentre os sintomas ocasionados pela doença é pertinente enfatizar os prejuízos ao sistema nervoso. Objetivo: O presente estudo tem o intuito de evidenciar o efeito benéfico da utilização de plantas medicinais frente aos sintomas de enfermidades do sistema nervoso através de dados científicos. Método: Trata-se de uma revisão da literatura com caráter descritivo; utilizando as plataformas SciELO, BVS e PubMed e como descritores: plantas medicinais, terapias complementares, doenças do sistema nervoso e COVID-19 nos idiomas português e inglês. A seleção das obras ocorreu após leitura do título e resumo, com data de publicação entre 2016-2021. Resultados: O processo de infecção ocasionado pelo SARS-CoV-2 pode gerar nos indivíduos sintomas que acometem o sistema nervoso como: transtornos de ansiedade e insônia, prejudicando a recuperação do paciente. Estudos descrevem que plantas medicinais que atuam sobre esse sistema a exemplo da Matricaria chamomilla L. (Camomila), do Cymbopogon citratus D.C. (Capim cidreira), da Passiflora incarnata L. (Maracujá) e da Melissa officinalis L. (Melissa) apresentam resultados satisfatórios. Ressalta-se que essas espécies poder ser preparadas utilizando a infusão e tendo como indicação terapêutica a ingesta de 150mL três vezes ao dia para alcance do efeito calmante nos transtornos de ansiedade e distúrbios do sono. É válido ressaltar que elas são constituídas de metabólitos secundários responsáveis pela atividade terapêutica e que podem ocasionar efeitos colaterais ao indivíduo, devendo o seu uso ser feito sob indicação e monitoramento de um profissional qualificado. Conclusão: O chá dessas ervas atua sobre o sistema nervoso auxiliando no enfrentamento dos sintomas psíquicos ocasionados pela COVID-19, tornando o seu consumo uma ferramenta complementar no auxílio de enfrentamento a essa doença.
APA, Harvard, Vancouver, ISO, and other styles
6

Guimarães, Beatriz Gonçalves, Nathanael Nascimento Dos Santos, Marcos Antonio Ferreira, Sthefany Dos Santos Brazil, and Morgana Sousa Da Cunha. "IMPORTÂNCIA DA UTILIZAÇÃO DE PLANTAS MEDICINAIS NO ENFRENTAMENTO DO SARs-COV2." In I Congresso Brasileiro de Doenças Infectocontagiosas On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/2220.

Full text
Abstract:
Introdução: Existem diferentes tipos de plantas medicinais comumente usadas no tratamento de síndromes agudas respiratórias, estudos têm mostrado que o uso de plantas medicinais possui grande probabilidade de gerar efeitos satisfatórios no tratamento contra Covid-19, com o intuito de minimizar as sequelas provocadas pela ação ou intoxicação medicamentosa. Devido à grande quantidade de substancias utilizadas na tentativa de inibir a progressão e complicação sistêmica provocado pela replicação viral, há um risco elevado no desenvolvimento de lesões hepáticas por abuso de medicamentos, tornando as alternativas naturais candidatas ao tratamento complementar de baixo risco. Objetivos: Esse estudo teve como finalidade levantar evidencias na literatura a respeito das propriedades anti-inflamatórias, presentes em plantas medicinais que possam ser utilizadas no tratamento de pacientes infectados por SARS-COV2. Material e métodos: A busca dos estudos foi realizada no mês de agosto/2021 nas bases de dados PUBMED. Utilizando a string de pesquisa: sars-cov2 AND medicinal AND plants, com o critério temporalmente de 2020 a 2021, intervalo de tempo que foram iniciadas as pesquisas científicas, resgatando 13 estudos no qual foram selecionados 10 artigos. Resultados: De acordo com a pesquisa realizada na base de dados, foi observado sugestivas ações terapêuticas em plantas medicinais com potencial preventivo e também como tratamento combinado de pacientes contaminados por SARS-COV2, já que estas plantas possuem substancias que agem contra os alvos estruturais do vírus. Conclusão: Existem plantas medicinais que possuem um grande potencial anti-inflamatório com propriedades inibitórias e bloqueadoras da replicação e transcrição viral, que podem ser utilizadas tanto no desenvolvimento de fármacos ou adotadas como terapias complementares anti-covid-19.
APA, Harvard, Vancouver, ISO, and other styles
7

Chow, SK, SS Yeap, E. Goh, K. Veerapen, and K. Lim. "THU0225 Complementary medicine in rheumatic diseases." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.757.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Asaro, Jessica. "Complementary and Alternative Medicine Usage across Nations." In Annual Worldwide Nursing Conference. Global Science & Technology Forum (GSTF), 2014. http://dx.doi.org/10.5176/2315-4330_wnc14.27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Klein, Gabriela, and Gabriella Barcelos. "OZONIOTERAPIA EM DOENÇAS DERMATOLÓGICAS: REVISÃO DE LITERATURA." In I Congresso On-line Nacional de Clínica Veterinária de Pequenos Animais. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/1880.

Full text
Abstract:
Introdução: A ozonioterapia consiste na administração de ozônio em diversas formulações em pacientes com o intuito medicinal. O ozônio é um gás que está presente na estratosfera e sua utilização na Medicina Veterinária tem se destacado recentemente. Este gás promove diversos efeitos no organismo, sendo eles, viricida, bactericida, oxidante e fungicida. Apresentando potencial para terapias complementares em diversos quadros, inclusive dermatológicos. Objetivos: Descrever o uso da ozonioterapia e seus benefícios para o tratamento de dermatopatias. Material e métodos: Foi realizada uma revisão bibliográfica de artigos indexados com as palavras-chave: dermatopatias, ozonioterapia e veterinária. Resultados: O uso da ozonioterapia é relatado em diversos quadros de dermatopatias, principalmente em cães e gatos, apesar de poucos estudos controlados existirem, diversos relatos de casos sugerem a eficácia da terapia na medicina veterinária. Em um dos relatos, a ozonioterapia resultou em diminuição de secreção, eliminação de crostas, crescimento total de pelos e resolução do prurido em pacientes com dermatite bacteriana difusa pelo método de “Bag” e insuflação retal. A administração da ozonioterapia pelas mesmas técnicas e associada com forma tópica com óleo de girassol ozonizado mostrou-se eficaz no tratamento de esporotricose, resultando em cicatrização tecidual total da lesão e contribuindo à cura clínica. Em outro relato em paciente felino com esporotricose, tratado com ozonioterapia, observou-se redução de edema. A terapia com ozônio também se mostrou eficaz em auxiliar casos de otite, podendo promover redução da infecção, do prurido e das lesões. Em casos de dermatite psicogênica, a ozonioterapia pode auxiliar na redução do tamanho da lesão e no controle do prurido. O ozônio ainda possui ação imunomoduladora, analgésica e anti-inflamatória, explicando sua contribuição na resolução de casos de prurido. Em estudo experimental, ratos submetidos a queimaduras superficiais apresentaram diminuição relevante das lesões com ozonioterapia, comparando com o grupo controle que não recebeu nenhum tipo de terapia. Conclusão: O uso da ozonioterapia como tratamento complementar de condições dermatológicas têm o potencial de reduzir secreção de feridas, área da ferida, prurido e edema, além de promover cicatrização tecidual e crescimento de pêlos. Portanto, a ozonioterapia pode ser considerada como terapia complementar para dermatites, otites e feridas
APA, Harvard, Vancouver, ISO, and other styles
10

Silva, Adriana Geraldina Vicente da, Fernanda Maria de Alencar Pereira, and Henriqueta Tereza do Sacramento. "PROJETO JARDIM DA SAÚDE DO TERRITÓRIO DO FORTE SÃO JOÃO: PROMOVENDO SAÚDE COM AS PLANTAS MEDICINAIS." In II Congresso Online Nacional de Práticas Integrativas e Complementares em Saúde. Congresse.me, 2021. http://dx.doi.org/10.54265/dnsx6862.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Complementary medicines"

1

Wu, Junsong, Xuefeng Liu, Hejing Liu, Yang Wang, Zhili Xiong, Minyi Shen, and Kun Zhong. Chinese Herbal Medicine Combined with Acupuncture-related therapy as Complementary Therapies for Diabetic Nephropathy: A Protocol for Systematic Review and Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0095.

Full text
Abstract:
Review question / Objective: Evaluating the efficacy of various Chinese herbal medicines combined with acupuncture-related therapies in the treatment of diabetic nephropathy. Information sources: We will search the following databases for relevant randomised controlled trials: PubMed, EMBASE, Cochrane Library, Scopus, OVID,Web of Science, Cochrane Central Register of Controlled Trials, China Biology Medicine (CBM), the China National Knowledge Infrastructure (CNKI), Wanfang data, and the Chinese Scientifific Journal Database (VIP). Search until April 10, 2022, with a combination of MeSH terms and free words.
APA, Harvard, Vancouver, ISO, and other styles
2

Kwesiga, Victoria, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Compliance to GMP guidelines for Herbal Manufacturers in East Africa: A Position Paper. Purdue University, November 2021. http://dx.doi.org/10.5703/1288284317428.

Full text
Abstract:
With the global increase in the use of traditional and complementary remedies for the prevention and treatment of illness, the quality and safety of these medicines have become a significant concern for all regulatory authorities. Herbal medicines are the most commonly used form of traditional and complementary medicines in the world and the efficacy and safety of herbal medicines, like conventional medicines, largely depends on their quality from planting to harvesting, preprocessing and final processing. Due to the inherent complexity of herbal medicines, often containing an array of active compounds, the primary processing of herbal medicines has a direct influence on their quality. Quality concerns are the reason why the medicines regulatory agencies insist that manufacturers of medicines strictly follow Good Manufacturing Practices since it is an essential tool to prevent instances of contamination, mix-ups, deviations, failures and errors. However, a strict application of GMP requirements is expensive and would drive the prices of the manufactured products up. As a result, a maturity level grading of facilities is proposed as a way of justifying the costs incurred for manufacturers desiring to reach a broader market and investing in continuous improvement. 36 Good Manufacturing Practice (GMP) inspection reports of local herbal manufacturers conducted by National Drug Authority were analyzed to establish the type and extent of deficiencies to GMP requirements for local herbal manufacturers in Uganda. The different GMP chapters and related sub-parameters constituted the variables used for the analysis of conformity to requirements. The primary outcome variable was the conclusion regarding compliance or noncompliance of the inspected local herbal manufacturing facility. GMP parameters that were frequently defaulted by local herbal manufacturers and the corresponding frequencies were identified. The Pearson Chi-square test was applied independently on each category to find the association that existed between conformity and the questions in each category. Only 22% (8) of the 30 inspected facilities were found to comply with GMP requirements, as per National Drug Authority (NDA) guidelines; while the majority of the facilities, 28 (78%), were found not to comply. Of the facilities inspected, 25 were undergoing GMP inspection for the first time. A total of 1,236 deficiency observations were made in the 36 inspection reports reviewed for the study. The mean for all deficiencies was 34.3, and the standard deviation was 15.829. 91.5% of the facilities did not have mechanisms for a record of market complaints; 80.9% did not meet documentation requirements; 78.9% did not have quality control measures in place, and 65.7% did not meet stores requirements. By encouraging a culture of self/voluntary improvement through the introduction of listing of manufacturers based on a maturity level grading, the National Drug Authority will improve the Herbal Medicines sector as per the mandate of improving the herbal medicine industry. Also, increased sensitization of all relevant stakeholders regarding the requirements for GMP should be intensified.
APA, Harvard, Vancouver, ISO, and other styles
3

Kin, Eunjin, Jungyoon Choi, and Sang Yeon Min. Efficacy and safety of herbal medicines external application with Tuina in congenital muscular torticollis : A systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0017.

Full text
Abstract:
Review question / Objective: By 3 to 4 months of age, infants can keep their necks upright and look into both eyes horizontally. But infants with CMT have a wry neck also known as a twisted neck. Complementary therapies have been commonly used to treat CMT, such as tuina, acupuncture, herbal medicine. Among them, external application of herbal medicine is non-surgical and non-invasive inventions so it can be used widely in East Asia. This review aims to evaluate any form of external application of herbal medicines in CMT, such as cream, oil, extract, form of patch, etc. Information sources: We will electronically search the following database 4 English databases(MEDLINE, PubMed, EMBASE, the Cochrane Central Register of Controlled Trials), 3 Chinese databases(China National Knowledge Infrastructure(CNKI), Chinese Scientific Journal Database(VIP), Wan Fang Database), 4 Korean medical databases(Oriental Medicine Advanced Searching Integrated System(OASIS), Korean Studies Information Service System(KISS), National Digital Science Links(NDSL), Research Information Sharing Service(RISS)) from their founding date to June 2022, without any language restrictions.
APA, Harvard, Vancouver, ISO, and other styles
4

OMAR, Zaliha Binti, Pooja Bell, Megan M. Bell, Urvashy Gopaul, Salmah Anim Abu Hassan, Chang Dae Lee, Hsiao-ju Cheng, et al. A scoping review of the scientific literature on publicly available databases for Complementary and Integrative Medicine (CIM) studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0043.

Full text
Abstract:
Review question / Objective: Review Questions: 1. What are the publicly available databases that can identified in Complementary and Integrative Medicine (CIM) studies? 2. What are the main characteristics of these studies? 3. Which of the CIM studies identified are associated with rehabilitation? Objectives 1. To create a tool for future research approaches based on lessons from the studies identified - hence promoting robust scientific protocols in its pursuit – for better acceptance by scientists, practitioners, and end-users. 2. To map and review open access databases that include CIM related data as defined by the National Institute of Health in 2012. 3. To highlight a subset of CIM studies that are associated with rehabilitation; to be identified as CIRM and promote it as an inclusive rehabilitative modality. 4. To guide future research on Complementary and Integrative Medicine. 5. To stimulate future research in Complementary and Integrative Medicine. 6. To promote evidence-based practice in Complementary and Integrative Medicine.
APA, Harvard, Vancouver, ISO, and other styles
5

Shumay, Dianne M., and Gertraud Maskarinec. A Longitudinal Study of Emotional Distress and the Use of Complementary and Alternative Medicine in Women with Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2004. http://dx.doi.org/10.21236/ada430066.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sun, Manqiang, Qi Chen, Tian Zhou, Dan Wang, Xueni Fang, Haoyue Pang, Yu Chen, et al. Efficacy and Safety of Complementary and Alternative Medicine Therapy for gastroparesis: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2020. http://dx.doi.org/10.37766/inplasy2020.10.0033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhou, Min, Qijun Liang, Qiulan Pei, Fan Xu, and Hang Wen. Chinese Herbs Medicine Qingre Huatan Prescription for Bronchiectasis as Complementary Therapy: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2020. http://dx.doi.org/10.37766/inplasy2020.5.0075.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shumay, Dianne M., and Gertraud Maskarinec. A Longitudinal Study of Emotional Distress and the Use of Complementary and Alternative Medicine in Women with Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2002. http://dx.doi.org/10.21236/ada411459.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hernandez, Theresa D. Using Complementary and Alternative Medicine (CAM) to Promote Stress Resilience in Those with Co-Occurring Mild TBI and PTSD. Fort Belvoir, VA: Defense Technical Information Center, February 2013. http://dx.doi.org/10.21236/ada575080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Shumay, Dianne M. A Longitudinal Study of Emotional Distress and the Use of Complementary and Alternative Medicine in women with Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2003. http://dx.doi.org/10.21236/ada421589.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Complementary medicines' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography